Sig Brokerage »

Apellis Pharmaceuticals shares owned by Sig Brokerage

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Sig Brokerage from 13F filings

Historical chart of Sig Brokerage investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Sig Brokerage consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Sig Brokerage

Quarter filed Position value Share count Share price at filing
2025-09-30 $917k 41k 22.63

More positions owned by Sig Brokerage

Meta Platforms Cl A Put Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Oracle Corporation (ORCL)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Apollo Global Mgmt Call Option (APO)
Booking Holdings (BKNG)
Ishares Msci Brazil Etf (EWZ)
Arm Holdings Sponsored Ads Call Option (ARM)
Coreweave Com Cl A (CRWV)
Thermo Fisher Scientific Call Option (TMO)
Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
UnitedHealth Put Option (UNH)

View all positions for Sig Brokerage

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Morgan Stanley
Wellington Management Company
Deep Track Capital
BlackRock
AQR Capital Management
Jennison Associates
State Street Corporation
EcoR1 Capital
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors

View all funds holding Apellis Pharmaceuticals